期刊文献+

含CpG基序寡核苷酸对rHBsAg免疫小鼠脾脏组织及细胞增殖的影响 被引量:2

Influence of CpG ODN on Histological Change and Lymphocyte Proliferation of Murine Spleen Immunized with rHBsAg
下载PDF
导出
摘要 目的探讨合成含CpG基序的寡核苷酸(CpGODN)与重组乙型肝炎表面抗原(rHBsAg)联合免疫对小鼠脾脏淋巴组织及细胞增殖的影响。方法经后腿胫骨前肌初次免疫BALB/c小鼠,2周后加强免疫1次;常规石蜡切片,H-E染色,观察脾脏组织学改变;3H-TdR掺入法检测免疫小鼠脾脏淋巴细胞增殖反应。结果抗原+CpG组脾脏可见明显的组织学改变。加CpG与不加CpG的2组比较,淋巴细胞增殖反应显著增强。结论CpGODN能够有效刺激小鼠脾脏组织T细胞区淋巴细胞增生,生发中心明显增大,而且能够显著增强淋巴细胞增殖反应。 Objective To explore the influence of combined immunization with the synthetic oligonuclentide containing CpG motif( CpG ODN) and rHBsAg on the histological change and lymphocyte proliferation of murine spleen. Methods Twenty-five BALB/c mice were randomly divided into four test groups and one control group, five for each,and immunized twice with rHBsAg,HB vaecine,rHBsAg + CpG ODN, HB vaccine + CpG ODN and physiological saline respectively, at an interval of 2 weeks. Prepare the mufine spleens into routine paraffin sections for observation of histological change by H-E staining. Determine the proliferation of lymphocytes by ^3H-TdR incorporation method. Results Significant histological change was observed in the murine spleens in rHBsAg + CpG ODN group. Compared with those of mice in rHBsAg and HB vaccine groups ,the lymphocyte proliferations of mice in rHBsAg + CpG ODN and HB vaccine + CpG ODN groups were significantly enhanced. However,compared with those of mice in control group,the lymphocyte proliferations of mice in all the four test groups were significandy enhanced. Conclusion CpG ODN caused the histological change of murine spleen, such as extension of germinal center, and enhanced the lymphocyte proliferation signifieandy. It indicated that CpG ODN might be a potential Thl type adjuvant of HB vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 2006年第2期105-107,共3页 Chinese Journal of Biologicals
基金 内蒙古自治区自然科学基金项目资助(200508010905).
  • 相关文献

参考文献11

  • 1Chu RS,Targoni OS,Krieg AM,et al.CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.J Exp Med,1997,186:1623-1631.
  • 2石艳春,杨贵贞.CpG ODN对rHBsAg免疫小鼠Th1/Th2型免疫应答的影响[J].中国免疫学杂志,2005,21(5):329-331. 被引量:8
  • 3Krieg AM.CpG motifs in bacterial DNA and their immune effects.Annual Rev Immunol,2002,20:709-760.
  • 4Klinman DM,Conover J,Coban C.Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides longterm protection against bacterial infection.Infect Immun,1999,67(11):5658-5663.
  • 5Gurunathan S,Wu CY,Freidag BL,et al.DNA vaccines:a key for inducing long-term cellular immunity.Cur Opin Immunol,2000,12:442-447.
  • 6石艳春.CpGDNA的识别、信号转导及对免疫细胞的效应[J].国外医学(免疫学分册),2002,25(6):281-284. 被引量:5
  • 7Weeratna RD,McCluskie MJ,Xu Y,et al.CpG DNA induces stronger immune responses with less toxicity than other adjuvants.Vaccine,2000,18(17):1755-1762.
  • 8Krieg AM,Wagner H.Causing a commotion in the blood:immunotherapy progress from bacterial to bacterial DNA.Immunol Today,2000,21 (10):521-526.
  • 9Abbs AK,Lichtman AH.Cellular and molecular immunology.Fifth Edition.Beijing:Peking University Medical Press,2004.298.
  • 10Kaech SM,Wherry EJ,Ahmed R.Effector and memory T cell differentiation:implications for vaccine development.Nature Rev Immunol,2002,2:251-262.

二级参考文献35

  • 1[1]Krieg A M. CpG motifs in bacterial DNA and their immune effects[J].Annual Rev Immunol,2002;20:709.
  • 2[2]Klinman DM, Conover J, Coban C. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection[J] .Infection and Immunity, 1999;67(11):5658.
  • 3[3]Krieg AM, Davis HL. Enhancing vaccines with immune stimulatory CpG DNA[J].Current Opinion in Molecular Theraputics,2001;3(1) :15.
  • 4[4]Krieg AM, MatsonS, Waldschmidt T J et al. CpG motifs in bacterial DNA trigger direct B-cell activation[J].Natuwe, 1995;374(6522):546.
  • 5[6]Weeratna R D, McCluakie M J, Xu Y et al.CpG DNA induces stronger immune responses with less toxicity than other adjuvants[J] .Vaccine,2000; 18(1): 1755.
  • 6[7]Krieg A M, Wagner H. Causing a commotion in the blood:immunotherapy progress from bacterial to bacterial DNA[J] .Immunology Today,2000; 21 (10) :521.
  • 7[8]Liang H, Nishiok Y, Reich C F et al. Activation of human B cells by phospho riothioate oligodeoxynucleotides[J]. J Clin Invest, 1996;98(5):1119.
  • 8Krieg AM, Davis HL.[J]. Current Opinion in Molecular Therapeutics, 2001, 3(1) :15-24.
  • 9Eastcott JW, Holmberg CJ,Dewhirst FE,et al.[J]. Vaccine,2001,19(13-14): 1636-1642.
  • 10Krieg AM,Wayner H. [J]. Immunology Today,2000,21(10) :521-526.

共引文献15

同被引文献14

  • 1郑源强,石艳春,杨贵贞.CpG ODN2006对乙型肝炎疫苗免疫BALB/c小鼠抗体产生的影响[J].中国生物制品学杂志,2006,19(3):223-224. 被引量:2
  • 2Hem SL, Hogenesch H. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation [J].Expert Rev Vaccines, 2007, 6 (5): 685-698.
  • 3Lee WM. Hepatitis B virus infection [J]. N Engl J Med, 1997, 337 (24): 1733-1745.
  • 4Wang S, Han Q, Zhang N, et ol. HBcAg18-27 epitope fused to HIV-Tat 49-57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice [J].Immunol Lett, 2010, 127(2): 143-149.
  • 5Wang X, Bao M, Wan M, et al. CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine [J]. Vaccine, 2008, 26 (15): 1893-1901.
  • 6Siegrist CA, Pihlgren M, Tougne C, et al. Coadministration of CpG oligonucleotides enhances the late affinity maturation process of human antihepatitis B vaccine response [J]. Vaccine, 2004, 23 (5): 615-622.
  • 7Jana M, Dasgupta S, Pal U, et al. IL-12 p40 homodimer, the socalled biologically inactive molecule, induces nitric oxide synthase in microglia via IL-12R beta 1 [J]. Glia, 2009, 57 (14): 1553- 1565.
  • 8Hasan UA,Abai AM,Harper DR,et al.Nucleic acid immunization:concepts and techniques associated with third generation vaccines.J Immunol Methods,1999,229(6):1-22.
  • 9Wang J,Zhu Q,Zhang T,et al.A pilot study on the combined therary of granulocyet-macrophage colony-stimulating failor and hepatitis B vaccine on chronichepatitis B virus carrier children.Chin Med J (Engl),2002,115(12):1824-1828.
  • 10Wild J,Gruner B,Metzger K,et al.Polyvatent vaccination againsthepatitis B surface and core antigen using a dicistronic expression plasmid.Vaccine,1998,16(7):353-360.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部